The DAT Shift: What’s Pulling Biotech Firms Into the Crypto Treasury Game?
2025 has shaped up to be a defining year for the emerging digital asset treasury movement, widely referred to as DATs. Research indicates that more than 100 publicly traded firms have embraced the DAT strategy, with a significant portion of them in the biotech sector—a field grappling with financial headwinds this year. Biotech’s Crypto Play: […]
